Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.5B | 1.6B | 1.8B |
Cost of revenue | 801.6M | 993.9M | 1.1B | 1.2B |
Gross profit | 447.5M | 511.2M | 562.8M | 639.1M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 500.9M | 477.3M | 451.4M | 495.1M |
Other operating expenses | — | — | — | -3.4M |
Operating income | -23.6M | 33.9M | 111.4M | 147.4M |
Non operating interest income | ||||
Income | 2.3M | 3.3M | 2.9M | 2M |
Expense | 15.1M | 13.6M | 13.8M | 13.8M |
Other income expense | — | — | — | — |
Pretax income | -58.1M | 23.8M | 111.1M | 131.3M |
Tax provision | -6.9M | 6.1M | 30.3M | 31.3M |
Net income | -51.3M | 17.7M | 80.8M | 100M |
Basic EPS | — | 1.1 | 4.8 | 6.0 |
Diluted EPS | — | 1.1 | 4.8 | 6.0 |
Basic average shares | — | 15.8M | 16.0M | 16.0M |
Diluted average shares | — | 15.8M | 16.0M | 16.0M |
EBITDA | 47.9M | 94.3M | 181.8M | 201.2M |
Net income from continuing op. | -51.3M | 17.7M | 80.8M | 100M |
Minority interests | 2.9M | -800K | -3.8M | -4.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |